4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-055315
CEO sold 2,960 shares at $42.56 ($125,978)
- CEO acquired 5,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2020-10-15 | Option exercise | +5,937 | 17,746 | D | ||
| DAVIS STEPHEN CEO | 2020-10-16 | Sale | −2,960 | $42.56 | $125,978 | 14,786 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2020-10-15 | Option exercise · Restricted Stock Units | −5,937 | 11,876 | D | ||
| Open-market sales · 2,960 sh · avg $42.56 · $125,978 | |||||||
Loading xslF345X03/doc4.xml…